Wood, M. E., Frazier, J. A., Nordeng, H. M., & Lapane, K. L. (2015). Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: An application of propensity score calibration to adjust for unmeasured confounding by migraine severity. Pharmacoepidemiol Drug Saf.
Citação norma ChicagoWood, Mollie E., Jean A. Frazier, Hedvig M.E Nordeng, and Kate L. Lapane. "Prenatal Triptan Exposure and Parent-reported Early Childhood Neurodevelopmental Outcomes: An Application of Propensity Score Calibration to Adjust for Unmeasured Confounding By Migraine Severity." Pharmacoepidemiol Drug Saf 2015.
MLA CitationWood, Mollie E., Jean A. Frazier, Hedvig M.E Nordeng, and Kate L. Lapane. "Prenatal Triptan Exposure and Parent-reported Early Childhood Neurodevelopmental Outcomes: An Application of Propensity Score Calibration to Adjust for Unmeasured Confounding By Migraine Severity." Pharmacoepidemiol Drug Saf 2015.